Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 653-659

  Chrastina, Adrian ^a   Schnitzer, Jan E ^a  

^a Proteogenomics Research Institute for Systems Medicine   (United States)

Author keywords

Ag nanoparticles; CT SPECT imaging; PVP; Radiolabeling

Indexed keywords

IODINE 125; POVIDONE; SILVER NANOPARTICLE; DIAGNOSTIC AGENT; METAL NANOPARTICLE; RADIOACTIVE IODINE; SILVER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; GAMMA SCINTIGRAPHY; IN VIVO STUDY; ISOTOPE LABELING; MOUSE; NANOANALYSIS; NANOFABRICATION; NON INVASIVE PROCEDURE; NONHUMAN; PARTICLE SIZE; PROCESS DEVELOPMENT; RAT; RETICULOENDOTHELIAL SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHOLE BODY IMAGING; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MONONUCLEAR PHAGOCYTE; NANOMEDICINE; SCINTISCANNING; TISSUE DISTRIBUTION;

MUS;

ANIMALS; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; MONONUCLEAR PHAGOCYTE SYSTEM; NANOMEDICINE; SILVER; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79952116282     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S11677     Document Type: Article

References (41)

1. Samuel U, Guggenbichler JP. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents. 2004;Suppl 1:S75-S78.
2. Chen J, Han CM, Lin XW, Tang ZJ, Su SJ. Effect of silver nanoparticle dressing on second degree burn wound. Zhonghua Wai Ke Za Zhi. 2006; 44:50-52.
3. Keck CM, Schwabe K. Silver-nanolipid complex for application to atopic dermatitis skin: rheological characterization, in vivo efficiency and theory of action. J Biomed Nanotechnol. 2009;5(4):428-436.
4. Cheng D, Yang J, Zhao Y. Antibacterial materials of silver nanoparticles application in medical appliances and appliances for daily use. Chin Med Equip J. 2004;4:26-32.
5. Sreekumar TV, Das A, Chandra L, Srivastava A, Rao KU. Inherently colored antimicrobial fibers employing silver nanoparticles. J Biomed Nanotechnol. 2009;5(1):115-120.
6. Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya RH. Functional finishing of cotton fabrics using silver nanoparticles. J Nanosci Nanotechnol. 2007;(6):1893-1897.
7. Fung MC, Bowen DL. Silver products for medical indications: riskbenefit assessment. J Toxicol Clin Toxicol. 1996;34(1):119-126.
8. Garza-Ocañas L, Ferrer DA, Burt J, et al. Biodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in rats. Metallomics. 2010;2:204-210.
9. Kim YS, Kim JS, Cho HS, et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol. 2008;20(6):575-583.
10. Ahamed M, Karns M, Goodson M, et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol. 2008;233(3):404-410.
11. Asharani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3(2):279-290.
12. Carlson C, Hussain SM, Schrand AM, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008;112(43):13608-13619.
13. Rahman MF, Wang J, Patterson TA, et al. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett. 2009;187(1):15-21.
14. Asharani PV, Wu YL, Gong Z, Valiyaveettil S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology. 2008;19(25):1-8.
15. Bar-llan O, Albrecht RM, Fako VE, Furgeson DY. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small. 2009;5(16):1897-1910.
16. Ji JH, Jung JH, Kim SS, et al. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol. 2007;19(10):857-871.
17. Sung JH, Ji JH, Park JD, et al. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci. 2009;108(2):452-461.
18. Takenaka S, Karg E, Roth C, et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. 2001;109 Suppl 4:547-551.
19. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silvercoated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma. 2006;60(3):648-652.
20. Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns. 2007;33(8):979-985.
21. Hoppe CE, Lazzari M, Pardiñas-Blanco I, López-Quintela MA. One-step synthesis of gold and silver hydrosols using poly(N-vinyl-2-pyrrolidone) as a reducing agent. Langmuir. 2006;22(16):7027-7034.
22. Gasparyan VK. Gold and silver nanoparticles in bioassay, cell visualization and therapy. Curr Clin Pharmacol. 2009;4(2):159-163.
23. Siddiqui TS, Jani A, Williams F, et al. Lanthanide complexes on Ag nanoparticles: designing contrast agents for magnetic resonance imaging. J Colloid Interface Sci. 2009;337(1):88-96.
24. Homan K, Shah J, Gomez S, et al. Combined Ultrasound and Photoacoustic Imaging of Pancreatic Cancer Using Nanocage Contrast Agents. Proc. of SPIE 2009;7177:71771M1-71771M6.
25. Vo-Dinh T, Wang HN, Scaffidi J. Plasmonic nanoprobes for SERS biosensing and bioimaging. J Biophotonics. 2010;3(1-2):89-102.
26. Sadauskas E, Wallin H, Stoltenberg M, et al. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol. 2007;4:10.
27. Cho WS, Cho M, Jeong J, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2009;236(1):16-24.
28. Semmler-Behnke M, Kreyling WG, Lipka J, et al. Biodistribution of 1.4- and 18-nm gold particles in rats. Small. 2008;4(12): 2108-2111.
29. 99mTc labelled model drug carriers - labeling, stability and organ distribution in rats. Nucl Med Biol. 2004;31(1):87-92.
30. Zavaleta CL, Smith BR, Walton I, et al. Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy. Proc Natl Acad Sci U S A. 2009;106(32): 13511-13516.
31. Schipper ML, Cheng Z, Lee SW, et al. microPET-based biodistribution of quantum dots in living mice. J Nucl Med. 2007;48(9): 1511-1518.
32. de Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29(12): 1912-1919.
33. Schnitzer JE. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Physiol. 1992;262(1 Pt 2):H246-H254.
34. Testa JE, Chrastina A, Oh P, et al. Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol. 2009;297(2): L251-L262.
35. Chrastina A, Valadon P, Massey KA, Schnitzer JE. Lung Vascular Targeting Using Antibody to Aminopeptidase P: CT-SPECT Imaging, Biodistribution and Pharmacokinetic Analysis. J Vasc Res. 2010; 47(6):531-543.
36. Lundh C, Lindencrona U, Schmitt A, Nilsson M, Forssell-Aronsson E. Biodistribution of free 211At and 125I-in nude mice bearing tumors derived from anaplastic thyroid carcinoma cell lines. Cancer Biother Radiopharm. 2006;21(6):591-600.
37. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005;19(7):975-983.
38. Smith BM, Zyromski NJ, Allison DC. Community-acquired methicillinresistant Staphylococcus aureus liver abscess requiring resection. Surgery. 2007;141(1):110-111.
39. Sangro B, Bilbao JI, Iñarrairaegui M, Rodriguez M, Garrastachu P, Martinez-Cuesta A. Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres. Dig Dis. 2009;27(2):164-169.
40. Sundram F, Chau TC, Onkhuudai P, Bernal P, Padhy AK. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2004;31(2):250-257.
41. Raoul JL, Boucher E, Roland V, Garin E. 131-iodine Lipiodol therapy in hepatocellular carcinoma. Q J Nucl Med Mol Imaging. 2009; 53(3):348-355.